David Andersson, PhD
King’s College London
London, United Kingdom
Disclosure(s): No financial relationships with ineligible companies to disclose
Joana Barroso, MD, PhD (she/her/hers)
Northwestern University
Chicago, IL, United States
Disclosure(s): No financial relationships with ineligible companies to disclose
Cindy Boer, PhD
Erasmus Medical Center
Sliedrecht, Netherlands
Disclosure(s): No financial relationships with ineligible companies to disclose
Luana Colloca, MD, PhD, MS
University of Maryland Baltimore
Baltimore, MD, United States
Disclosure(s): No financial relationships with ineligible companies to disclose
Franziska Denk, PhD
King's College London
London, United Kingdom
Disclosure(s): Cellectricon: Advisor or Review Panel Member (Ongoing); Mundipharma: Grant/Research Support (Terminated); Ono Pharmaceuticals: Grant/Research Support (Ongoing)
Mary-Ann Fitzcharles, MD, FRCPC, MBChB
McGill University
Montreal-West, QC, Canada
Disclosure(s): No financial relationships with ineligible companies to disclose
Helene Langevin, MD
NIH/NCCIH
Bethesda, MD, United States
Disclosure(s): No financial relationships with ineligible companies to disclose
Yvonne Lee, MD, MMSc
Northwestern University
Chicago, IL, United States
Disclosure(s): Cigna-Express Scripts: Ownership Interest (Terminated, May 8, 2023); Eli Lilly: Medical Writer (Terminated, February 15, 2022); Pfizer: Grant/Research Support (Terminated, June 30, 2022); Sanofi: Medical Writer (Terminated, November 10, 2022)
Anne-Marie Malfait, MD, PhD
Rush University
Oak Park, IL, United States
Disclosure(s): 23and Me: Consultant (Ongoing); LG: Consultant (Ongoing); Orion: Consultant (Ongoing)
Fransiska Malfait, MD, PhD
Ghent University Hospital
Gent, Belgium
Disclosure(s): No financial relationships with ineligible companies to disclose
Jason McDougall, PhD, BSc
Dalhousie University
Halifax, NS, Canada
Disclosure(s): No financial relationships with ineligible companies to disclose
Rachel Miller, PhD, BS
Rush University Medical Center
Chicago, IL, United States
Disclosure(s): No financial relationships with ineligible companies to disclose
Jeffrey Mogil
McGill University
Montreal, QC, Canada
Disclosure(s): No financial relationships with ineligible companies to disclose
Andrea Nackley, PhD
Duke University School of Medicine
Durham, NC, United States
Disclosure(s): No financial relationships with ineligible companies to disclose
Tuhina Neogi, MD, PhD
Boston University School of Medicine
Brookline, MA, United States
Disclosure(s): No financial relationships with ineligible companies to disclose
Theodore Price, PhD
University of Texas, Dallas
Richardson, TX, United States
Disclosure(s): 4E Therapeutics: Advisor or Review Panel Member (Ongoing), Intellectual Property/Patents (Ongoing), Ownership Interest (Ongoing); AbbVie/Abbott: Grant/Research Support (Ongoing); Doloromics: Advisor or Review Panel Member (Ongoing), Ownership Interest (Ongoing); Grunenthal: Grant/Research Support (Ongoing); Hoba Therapeutics: Grant/Research Support (Ongoing); Merck: Grant/Research Support (Ongoing); PARMedics: Advisor or Review Panel Member (Ongoing), Ownership Interest (Ongoing)
Camilla Svensson, PhD, MSc
Karolinska Institutet
Stockholm, Sweden
Disclosure(s): Cellectricon: Advisor or Review Panel Member (Ongoing); Eli Lilly: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Netris Pharma: Grant/Research Support (Ongoing); Oblique Therapeutics: Officer or Board Member (Ongoing); UCB: Consultant (Ongoing)
David Walsh, PhD, FRCP
University of Nottingham
Nottingham, United Kingdom
Disclosure(s): AbbVie/Abbott: Consultant (Ongoing); AKL Research & Development Limited: Consultant (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing), Grant/Research Support (Ongoing); Orion Pharma: Grant/Research Support (Ongoing)
Pain due to rheumatic and musculoskeletal diseases are common symptom rheumatologists are asked to assess and manage. The Basic and Clinical Research Conference “Pain in Rheumatic Disease” spans the spectrum of pain research and clinical treatment. Experts from across the globe will review the current and future state of the science of pain, the underlying mechanisms, and what we can do to help our patients. In addition, we will host a poster viewing session during the lunch hour.
Funding for this conference was made possible (in part) by (1U13AR081683-01) from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). The views expressed in written conference materials or publications by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Service; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.Learning Objectives:
Speaker: Anne-Marie Malfait, MD, PhD – Rush University
Speaker: Tuhina Neogi, MD, PhD – Boston University School of Medicine
Speaker: Theodore Price, PhD – University of Texas, Dallas
Speaker: Joana Barroso, MD, PhD (she/her/hers) – Northwestern University
Speaker: David Walsh, PhD, FRCP – University of Nottingham
Speaker: Andrea Nackley, PhD – Duke University School of Medicine
Speaker: Franziska Denk, PhD – King's College London
Speaker: Cindy Boer, PhD – Erasmus Medical Center
Speaker: Jeffrey Mogil – McGill University
Speaker: Camilla Svensson, PhD, MSc – Karolinska Institutet
Speaker: Yvonne C. Lee, MD, MMSc – Northwestern University
Speaker: Rachel Miller, PhD, BS – Rush University Medical Center
Speaker: David Andersson, PhD – King’s College London
Speaker: Fransiska Malfait, MD, PhD – Ghent University Hospital
Speaker: Helene Langevin, MD – NIH/NCCIH
Speaker: Mary-Ann Fitzcharles, MD, FRCPC, MBChB – McGill University
Speaker: Jason McDougall, PhD, BSc – Dalhousie University
Speaker: Luana Colloca, MD, PhD, MS – University of Maryland Baltimore
Speaker: Anne-Marie Malfait, MD, PhD – Rush University
Speaker: Tuhina Neogi, MD, PhD – Boston University School of Medicine